I have tried it at the address below - it is experimental site called PowerLabs. You can't search the Web, but only Wikipedia and only using tripples: something-connection-something.
This is what you get for FDA - approves - drugs
-
Oprelvekin:
"The FDA has approved the drug very recently, in 2006."
Criticism of the Food and Drug Administration:
"Some critics believe that the FDA
has been too willing to overlook safety concerns in approving new
drugs, and is slow to withdraw approved drugs once evidence shows them
to be unsafe."
Criticism of the Food and Drug Administration:
"Troglitazone and rofecoxib (trade name Vioxx) are high-profile
examples of drugs approved by the FDA which were later withdrawn from
the market for posing unacceptable risks to patients."
Pramlintide:
"Symlin is the only drug approved by the FDA to lower blood sugar in type 1 diabetics since insulin's discovery in the early 1920s."
Omapatrilat:
"This drug from BMS was not approved by the FDA due to angioedema safety concerns [Reference: Joshi Venugopal. (2003) Pharmacological modulation of the natriuretic peptide system."
National Drug Code System:
"Inclusion of a drug in the directory does not mean that the FDA has approved the drug or that Medicare, Medicaid or other payers will reimburse for it."
Torisel:
"Temsirolimus is an intravenous drug for the treatment of renal cell carcinoma (RCC), developed by Wyeth Pharmaceuticals and approved by the FDA in late May 2007."
Monoamine oxidase inhibitor:
"Two such drugs, selegiline and rasagiline have been approved by the
FDA to not require dietary restrictions, except in high dosage
treatment."
Neuropsychopharmacology:
"The FDA has approved drugs which selectively act on each of the major
neurotransmitters such as NE reuptake inhibitor antidepressants, DA
blocker anti-psychotics, and GABA agonist tranquilizers
(benzodiazepines)."
Insulin-like growth factor 1:
"In August 2005, the FDA approved Tercica's
IGF-1 drug, Increlex, as replacement therapy for severe primary IGF-1
deficiency based on clinical trial data from 71 patients."
Lipodissolve:
"One of these businesses states on its website that "Pharmacies are
permitted to compound drugs pursuant to a valid
patient/physician/pharmacist relationship - even if the drugs have not
been approved by the FDA.""
Lipodissolve:
"On August 31, fig. a company that manages or operates 15 medical body shaping centers offering the Lipodissolve procedure ((http://www.fig.com/)), filed a petition for a temporary restraining order in Shawnee, Kansas to prevent the ban from going into effect (http://www.bizjournals.com/stlouis/stories/2007/09/10/story15.html?b=1189396800%5E1516650).
.Fig states on their public website "Pharmacies are permitted to
compound drugs pursuant to a valid patient/physician/pharmacist
relationship - even if the drugs have not been approved by the FDA." (http://www.fig.com/mythvfact.html)."
Off-label use:
"However, once the FDA
approves a drug for prescription use, they do not attempt to regulate
the practice of medicine, and so the physician makes decisions based on
her or his best judgment."
Abortion-related violence:
"October 1, 2000: A Catholic priest drove his car into the Northern Illinois Health Clinic after learning that the FDA had approved the drug RU-486."
Eli Lilly Controversy:
"The drug instead was approved by the FDA for use in the treatment of
adult ADHD, which has become its more common use."
Generic drug:
"The FDA must approve generic drugs just as innovator drugs must be approved."
Drotrecogin alfa:
"The FDA approved the drug in 2001 as was the case with the drug authorities in many other countries."
Natalizumab:
"After an intensive safety evaluation, the drug was re-approved by the FDA
as a potentially significant advancement over existing therapies and
returned to the marketplace under a program of restricted distribution
and regular patient evaluations."
-----Original Message-----
From: paola.dimaio@xxxxxxxxx [mailto:paola.dimaio@xxxxxxxxx]
Sent: Friday, February 15, 2008 12:19 AM
To: '[ontolog-forum]'
Subject: Re: [ontolog-forum] language ambiguity (was: Axiomatic ontology)
re. powerset, yes I have a seen a demo at ISWC in Busan Korea. The guy
dId a search for 'fda approved drugs' and in the retrieved list there
was also 'marijuana'
So we wondered if marijuana was approved, and when we clicked on it
said 'not approved'
'it also picks up negative instanes' said the guy. hehehe.. there is a
video somewhere on the web, unless they edited it out...
On 2/15/08, Rob Freeman wrote:
> The most ambitious effort I know of along the lines of using classical
> NLP to try and label the Web for meaning is the very trendy new Web
> startup Powerset:
>
> http://www.powerset.com
>
> As I recall they have got funding in the area of $10+ M to index the
> whole Web. They've bought rights to PARC's NLP technology.
>
> Are people here aware of that company?
>
> I have a soft spot for any NLP effort, but anyone who has seen my
> posts here will probably realize I think they have got the problem
> exactly the wrong way around. Instead of using NLP to help with
> search, I think they should be using something like search to fix NLP
> (and improve search at the same time.)
>
> But that's another story. The effort is interesting.
>
> -Rob
>
> On Thu, Feb 14, 2008 at 7:29 PM, wrote:
> >
> >
> > Dear Pat,
> >
> > This looks somewhat similar to what I have seen from a couple of EC funded
> > research projects I was a reviewer for over the last several years. There
> is
> > no doubt that if you consider this sort of thing to be a tool for computer
> > assisted ontology development, then it can be very helpful, particularly
> > where we are talking about extracting brute facts. However, if you are
> > talking about more general ontology extraction, then of course the
> ontolgoy
> > produced is going to be no better than that of the document considered,
> and
> > there are the usual issues with ambiguity that computers usually struggle
> > with, especially using words with different senses in close proximity.
> >
> >
> >
> > Regards
> >
> > Matthew West
>
> _________________________________________________________________
> Message Archives: http://ontolog.cim3.net/forum/ontolog-forum/
> Subscribe/Config: http://ontolog.cim3.net/mailman/listinfo/ontolog-forum/
> Unsubscribe: mailto:ontolog-forum-leave@xxxxxxxxxxxxxxxx
> Shared Files: http://ontolog.cim3.net/file/
> Community Wiki: http://ontolog.cim3.net/wiki/
> To Post: mailto:ontolog-forum@xxxxxxxxxxxxxxxx
>
>
--
Paola Di Maio
School of IT
www.mfu.ac.th
*********************************************
_________________________________________________________________
Message Archives: http://ontolog.cim3.net/forum/ontolog-forum/
Subscribe/Config: http://ontolog.cim3.net/mailman/listinfo/ontolog-forum/
Unsubscribe: mailto:ontolog-forum-leave@xxxxxxxxxxxxxxxx
Shared Files: http://ontolog.cim3.net/file/
Community Wiki: http://ontolog.cim3.net/wiki/
To Post: mailto:ontolog-forum@xxxxxxxxxxxxxxxx
_________________________________________________________________
Message Archives: http://ontolog.cim3.net/forum/ontolog-forum/
Subscribe/Config: http://ontolog.cim3.net/mailman/listinfo/ontolog-forum/
Unsubscribe: mailto:ontolog-forum-leave@xxxxxxxxxxxxxxxx
Shared Files: http://ontolog.cim3.net/file/
Community Wiki: http://ontolog.cim3.net/wiki/
To Post: mailto:ontolog-forum@xxxxxxxxxxxxxxxx (01)
|